| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Esperion Therapeutics, Inc. (ESPR) has 9 insiders with recent SEC Form 4 filings, including 5 buys and 6 sells. ESPR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.47M | $4.65M | - | |
| CFO | 467.5K | $1.48M | - | |
| Other | 385.9K | $1.22M | - | |
| Other | 380.0K | $1.20M | - | |
| Dir | 177.5K | $561.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2022 | Foody Joanne M.73 | Chief Medical Officer | Sell | 3,901 | $6.55 | $25,551.55 | -3.5% | +16.8% | -76.5% | |
| Jul 19, 2022 | Warren Eric60 | Chief Commercial Officer | Sell | 431 | $6.58 | $2,836.84 | -0.8% | +16.8% | -76.5% | |
| Jun 17, 2022 | Koenig Sheldon L.60 | President And CEO | Sell | 4,552 | $4.99 | $22,719.03 | -2.3% | +34.3% | -74.6% | |
| Jun 17, 2022 | Warren Eric60 | Chief Commercial Officer | Sell | 256 | $4.90 | $1,254.40 | -0.5% | +34.3% | -74.6% | |
| Jun 2, 2022 | Carroll J Martin53 | Director | Buy | 5,000 | $5.64 | $28,179.50 | New | +32.7% | -75.8% | |
| May 17, 2022 | Warren Eric60 | Chief Commercial Officer | Sell | 196 | $5.98 | $1,172.28 | -0.4% | +2.3% | -73.0% | |
| Mar 17, 2022 | Koenig Sheldon L.60 | President And CEO | Sell | 571 | $4.58 | $2,615.18 | -0.3% | +4.5% | -69.6% | |
| May 24, 2021 | Biotech Target N V55 | 10% Owner | Buy | 100,000 | $20.22 | $2,021,620.00 | +2.3% | -31.9% | -71.4% | |
| May 19, 2021 | Biotech Target N V55 | 10% Owner | Buy | 200,000 | $20.37 | $4,073,960.00 | +4.8% | -30.3% | -69.8% | |
| May 6, 2021 | Biotech Target N V55 | 10% Owner | Buy | 230,000 | $20.21 | $4,648,482.00 | +2.9% | -32.7% | -73.5% |